Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-368.95	-299.62	-152.15	-95.99	-89.06	-32.61
Depreciation & Amortization	0.52	0.47	0.11	0.02	-0.85	0.18
Stock-Based Compensation	43.39	37.93	20.8	11.49	8.89	3.01
Other Adjustments	13.14	-2.88	-6.1	-1.88	6.67	2.2
Changes in Other Operating Activities	18.7	22.99	2.66	-5.82	6.75	3.51
Operating Cash Flow	-293.2	-241.1	-134.68	-92.18	-67.6	-23.71
Capital Expenditures	-0.47	-0.63	-0.97	-0.06	-0.06	-
Purchases of Intangible Assets	-0.15	-	-	-	-	-
Purchases of Investments	-431.02	-310.45	-703.02	-224.93	-148.49	-
Proceeds from Sale of Investments	487.83	506.16	278.96	185.56	78	-
Other Investing Activities	-15.05	-0.8	-	-	-	-4.2
Investing Cash Flow	41.15	194.29	-425.03	-39.43	-70.55	-4.2
Long-Term Debt Issued	11.67	23.34	-	24.74	19.82	4.92
Net Long-Term Debt Issued (Repaid)	11.67	23.34	-	24.74	19.82	4.92
Issuance of Common Stock	309.39	306.98	645.91	116.06	88.21	51.73
Repurchase of Common Stock	-	-	-0.01	-	-	-
Net Common Stock Issued (Repurchased)	309.39	306.98	645.9	116.06	88.21	51.73
Other Financing Activities	-19.66	-21.42	-39.23	-7.26	-6.1	-2.77
Financing Cash Flow	311.31	308.9	606.67	133.54	101.93	53.88
Net Cash Flow	59.26	262.08	46.97	1.93	-36.22	25.97
Free Cash Flow	-293.66	-241.73	-135.65	-92.24	-67.66	-23.71
Free Cash Flow Per Share	-4.41	-3.76	-2.45	-2.16	-2.55	-1.76
Levered Free Cash Flow	-338.53	-253.45	-150.36	-77.11	-63.4	-24
Unlevered Free Cash Flow	-364.65	-292.64	-165.38	-107.88	-85.07	-30.72

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q